Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $41.3900 (-1.19%) ($41.2700 - $41.3900) on Mon. Apr. 11, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.14% (three month average) | RSI | 75 | Latest Price | $41.3900(-1.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.1% a day on average for past five trading days. | Weekly Trend | HALO advances 4.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(49%) IWO(44%) IWM(43%) IWN(42%) IWC(40%) | Factors Impacting HALO price | HALO will decline at least -1.07% in a week (0% probabilities). VIXM(-23%) UUP(-10%) VXX(-8%) TBT(-4%) GLD(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.07% (StdDev 2.14%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $41.8(-0.98%) | 10 Day Moving Average | $41.3(0.22%) | 20 Day Moving Average | $39.44(4.94%) | To recent high | -2.2% | To recent low | 29.5% | Market Cap | $5.657b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |